dactinomycin has been researched along with Multiple Organ Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohlinger, I; Gantner, F; Germann, PG; Leist, M; Tiegs, G; Wendel, A | 1 |
| Garcia, I; Maier, RV; Mendez, C | 1 |
| Baker, A; D'Antiga, L; Mieli-Vergani, G; Pritchard, J; Pryor, D | 1 |
3 other study(ies) available for dactinomycin and Multiple Organ Failure
| Article | Year |
|---|---|
Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models.
Topics: Animals; Apoptosis; Dactinomycin; DNA; Galactosamine; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Multiple Organ Failure; Proteins; RNA; Shock, Septic; Tumor Necrosis Factor-alpha | 1995 |
Oxidants augment endotoxin-induced activation of alveolar macrophages.
Topics: Animals; Blood Coagulation Factors; Cells, Cultured; CHO Cells; Cricetinae; Dactinomycin; Diamide; Electrophoresis; Endotoxins; Glucose Oxidase; Glutathione; Humans; Infant, Newborn; Macrophages, Alveolar; Male; Multiple Organ Failure; NF-kappa B; Oxidants; Oxidation-Reduction; Oxidative Stress; Protein Synthesis Inhibitors; Rabbits; Reactive Oxygen Species; Respiratory Distress Syndrome, Newborn; RNA, Messenger; Superoxides; Tumor Necrosis Factor-alpha; Xanthine Oxidase | 1996 |
Veno-occlusive disease with multi-organ involvement following actinomycin-D.
Topics: Antibiotics, Antineoplastic; Child, Preschool; Constriction, Pathologic; Dactinomycin; Humans; Infant; Kidney Neoplasms; Male; Multiple Organ Failure; Rhabdomyosarcoma; Testicular Neoplasms; Vascular Diseases; Wilms Tumor | 2001 |